The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical utility of [18F]fluoroestradiol (FES) PET/CT to guide second-line treatment decision in patients with ER-positive HER2-negative metastatic breast cancer progressing on first-line endocrine therapy.
 
Hannah Linden
Leadership - Evolent (I); Progyny (I)
Stock and Other Ownership Interests - Evolent (I)
Consulting or Advisory Role - GE Healthcare; Gilead Sciences; Lilly; Novartis; Pfizer; Sanofi
Research Funding - Pfizer (Inst); Sanofi/Aventis (Inst); Tolmar (Inst); Veru; Zeno Pharmaceuticals (Inst); Zionexa (Inst); Zymeworks (Inst)
 
Stephanie van de Ven
Employment - GE Healthcare
 
Paul La Porte
Consulting or Advisory Role - GE Healthcare
 
Peter Conti
Travel, Accommodations, Expenses - GE Healthcare
 
Parvin Peddi
Research Funding - BioNTech SE; Briacell
 
Joanne Mortimer
Consulting or Advisory Role - AstraZeneca; GE Healthcare; Pfizer
Research Funding - AstraZeneca
 
Christiana Brenin
No Relationships to Disclose
 
David Buck
Consulting or Advisory Role - Novartis
 
Amol Takalkar
Consulting or Advisory Role - GE Healthcare; Lantheus Medical Imaging
 
Julia McGuinness
Consulting or Advisory Role - AstraZeneca; Gilead Sciences
Speakers' Bureau - OncLive Clinical Congress Consultants; WebMD
Research Funding - GlaxoSmithKline (Inst); Greenwich Biosciences (Inst); HiberCell (Inst); Jazz Pharmaceuticals (Inst); Relay Therapeutics (Inst); Relay Therapeutics (Inst)
 
Edgar Cheng
No Relationships to Disclose
 
Amol Rao
Consulting or Advisory Role - Tempus
 
Gary Ulaner
Honoraria - GE Healthcare; Lantheus Medical Imaging
Consulting or Advisory Role - GE Healthcare; ImaginAb; Lantheus Medical Imaging; POINT Biopharma
Speakers' Bureau - GE Healthcare; Lantheus Medical Imaging
Research Funding - GE Healthcare; Genentech; Lantheus Medical Imaging
Expert Testimony - GE Healthcare
Travel, Accommodations, Expenses - Lantheus Medical Imaging
 
Deborah Lindquist
No Relationships to Disclose
 
Adam Brufsky
Consulting or Advisory Role - Agendia; Daiichi Sankyo/Lilly; Eisai; Genentech/Roche; General Electric; Gilead Sciences; Lilly; Merck; Myriad Pharmaceuticals; Novartis; Pfizer; Puma Biotechnology
Research Funding - AstraZeneca/Daiichi Sankyo (Inst); Gilead Sciences (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Puma Biotechnology (Inst); Roche/Genentech (Inst)
Expert Testimony - Pfizer; Sanofi
 
Lanell Peterson
No Relationships to Disclose
 
Jennifer Specht
Honoraria - BioNTech SE; Daiichi Sankyo; SCRIPPS Research Institute; Sensei Biotherapeutics
Consulting or Advisory Role - BioNTech SE; Boehringer Ingelheim; Daiichi Sankyo; GE Healthcare; Lyell Immunopharma Inc
Research Funding - A2 Biotherapeutics (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Biocity (Inst); Carisma Therapeutics (Inst); Celcuity (Inst); Genentech (Inst); Lyell Immunopharma (Inst); Merck (Inst); OnKure (Inst); Pfizer (Inst); Seagen (Inst); Xencor (Inst)
Patents, Royalties, Other Intellectual Property - UW CoMotion - Patent Royalty for ROR1 CAR (Inst)
Travel, Accommodations, Expenses - A2 Biotherapeutics; Dava Oncology; GE Healthcare; GlaxoSmithKline; iwCAR-T; Nektar
 
Terence Wong
Consulting or Advisory Role - GE Healthcare; Novartis; Progenics; Telix Pharmaceuticals
Research Funding - Blue Earth Diagnostics (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Progenics